Ken Griffin Moderna, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Moderna, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,151,300 shares of MRNA stock, worth $84.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,151,300

Previous 1,788,000 20.32%

Holding current value

$84.7 Million

Previous $212 Million 32.29%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $13.2 Million - $26 Million	-208,080 Reduced 45.19%	252,376 $16.9 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $19 Million - $31.3 Million	188,119 Added 69.08%	460,456 $54.7 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $22.9 Million - $31 Million	-268,679 Reduced 49.66%	272,337 $29 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.47 Million - $3.72 Million	35,601 Added 7.04%	541,016 $53.8 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $39.1 Million - $51.4 Million	406,060 Added 408.7%	505,415 $52.2 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $14.7 Million - $19.8 Million	-123,630 Reduced 55.44%	99,355 $12.1 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $16.6 Million - $24.1 Million	122,347 Added 121.57%	222,985 $34.2 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2.02 Million - $3.58 Million	17,061 Added 20.41%	100,638 $18.1 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $871,592 - $1.43 Million	-7,382 Reduced 8.12%	83,577 $9.88 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $8.22 Million - $12.4 Million	70,149 Added 337.09%	90,959 $13 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $63.1 Million - $117 Million	-498,642 Reduced 95.99%	20,810 $3.59 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $54.9 Million - $89.6 Million	243,006 Added 87.9%	519,452 $132 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $97.2 Million - $212 Million	-438,233 Reduced 61.32%	276,446 $106 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $67.2 Million - $122 Million	-517,219 Reduced 41.99%	714,679 $168 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $16 Million - $27.3 Million	146,980 Added 13.55%	1,231,898 $161 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $70.2 Million - $181 Million	1,068,494 Added 6505.69%	1,084,918 $113 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $2.18 Million - $3.8 Million	-40,077 Reduced 70.93%	16,424 $1.16 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $1.37 Million - $3.7 Million	46,262 Added 451.82%	56,501 $3.63 Million
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $1.53 Million - $2.71 Million	-85,786 Reduced 89.34%	10,239 $307,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $338,638 - $517,316	24,310 Added 33.9%	96,025 $1.88 Million
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $7.73 Million - $11.4 Million	-630,763 Reduced 89.79%	71,715 $1.14 Million
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $7.44 Million - $15.4 Million	543,370 Added 341.51%	702,478 $10.3 Million
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $2.3 Million - $3.77 Million	159,108 New	159,108 $0

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account